Senator Mike Lee Introduces the Biosimilar Red Tape Elimination Act to Eliminate Switching Study Requirement for Biosimilar Interchangeability | Venable LLP
On November 17, 2022, Senator Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase biosimilar competition and reduce patient costs by prohibiting the FDA...
European Medicines Agency Regulatory Agency Senator Mike Lee Red Tape Elimination Biologics Price Competition Innovation Act
Source: jdsupra.com